Literature DB >> 24916688

Mononuclear cells from dedifferentiation of mouse myotubes display remarkable regenerative capability.

Zhong Yang1, Qiang Liu, Robert J Mannix, Xiaoyin Xu, Hongli Li, Zhiyuan Ma, Donald E Ingber, Paul D Allen, Yaming Wang.   

Abstract

Certain lower organisms achieve organ regeneration by reverting differentiated cells into tissue-specific progenitors that re-enter embryonic programs. During muscle regeneration in the urodele amphibian, postmitotic multinucleated skeletal myofibers transform into mononucleated proliferating cells upon injury, and a transcription factor-msx1 plays a role in their reprograming. Whether this powerful regeneration strategy can be leveraged in mammals remains unknown, as it has not been demonstrated that the dedifferentiated progenitor cells arising from muscle cells overexpressing Msx1 are lineage-specific and possess the same potent regenerative capability as their amphibian counterparts. Here, we show that ectopic expression of Msx1 reprograms postmitotic, multinucleated, primary mouse myotubes to become proliferating mononuclear cells. These dedifferentiated cells reactivate genes expressed by embryonic muscle progenitor cells and generate only muscle tissue in vivo both in an ectopic location and inside existing muscle. More importantly, distinct from adult muscle satellite cells, these cells appear both to fuse with existing fibers and to regenerate myofibers in a robust and time-dependent manner. Upon transplantation into a degenerating muscle, these dedifferentiated cells generated a large number of myofibers that increased over time and replenished almost half of the cross-sectional area of the muscle in only 12 weeks. Our study demonstrates that mammals can harness a muscle regeneration strategy used by lower organisms when the same molecular pathway is activated. © AlphaMed Press.

Entities:  

Keywords:  Adult stem cells; Cell cycle; Cellular therapy; In vivo optical imaging; Muscle stem cells; Reprogramming; Skeletal muscle; Transcription factors

Mesh:

Substances:

Year:  2014        PMID: 24916688      PMCID: PMC4422173          DOI: 10.1002/stem.1742

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  68 in total

1.  Dedifferentiation of mammalian myotubes induced by msx1.

Authors:  S J Odelberg; A Kollhoff; M T Keating
Journal:  Cell       Date:  2000-12-22       Impact factor: 41.582

2.  Mouse digit tip regeneration is mediated by fate-restricted progenitor cells.

Authors:  Jessica A Lehoczky; Benoît Robert; Clifford J Tabin
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

3.  Epidermal growth factor induces adult human islet cell dedifferentiation.

Authors:  Stephen C Hanley; Béatrice Assouline-Thomas; Julia Makhlin; Lawrence Rosenberg
Journal:  J Endocrinol       Date:  2011-09-20       Impact factor: 4.286

4.  Autologous minced muscle grafts: a tissue engineering therapy for the volumetric loss of skeletal muscle.

Authors:  B T Corona; K Garg; C L Ward; J S McDaniel; T J Walters; C R Rathbone
Journal:  Am J Physiol Cell Physiol       Date:  2013-07-24       Impact factor: 4.249

Review 5.  Regeneration of skeletal muscle.

Authors:  Neill J Turner; Stephen F Badylak
Journal:  Cell Tissue Res       Date:  2011-06-11       Impact factor: 5.249

6.  Mammalian myotube dedifferentiation induced by newt regeneration extract.

Authors:  C J McGann; S J Odelberg; M T Keating
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

Review 7.  Satellite cells, the engines of muscle repair.

Authors:  Yu Xin Wang; Michael A Rudnicki
Journal:  Nat Rev Mol Cell Biol       Date:  2011-12-21       Impact factor: 94.444

8.  Fundamental differences in dedifferentiation and stem cell recruitment during skeletal muscle regeneration in two salamander species.

Authors:  Tatiana Sandoval-Guzmán; Heng Wang; Shahryar Khattak; Maritta Schuez; Kathleen Roensch; Eugeniu Nacu; Akira Tazaki; Alberto Joven; Elly M Tanaka; András Simon
Journal:  Cell Stem Cell       Date:  2013-11-21       Impact factor: 24.633

9.  Down-regulation of myogenin can reverse terminal muscle cell differentiation.

Authors:  Nikolaos P Mastroyiannopoulos; Paschalis Nicolaou; Mustafa Anayasa; James B Uney; Leonidas A Phylactou
Journal:  PLoS One       Date:  2012-01-03       Impact factor: 3.240

10.  Clonally dominant cardiomyocytes direct heart morphogenesis.

Authors:  Vikas Gupta; Kenneth D Poss
Journal:  Nature       Date:  2012-04-25       Impact factor: 49.962

View more
  5 in total

1.  Non-viral, Tumor-free Induction of Transient Cell Reprogramming in Mouse Skeletal Muscle to Enhance Tissue Regeneration.

Authors:  Irene de Lázaro; Acelya Yilmazer; Yein Nam; Sara Qubisi; Fazilah Maizatul Abdul Razak; Hans Degens; Giulio Cossu; Kostas Kostarelos
Journal:  Mol Ther       Date:  2018-10-24       Impact factor: 11.454

Review 2.  Regeneration and Regrowth Potentials of Digit Tips in Amphibians and Mammals.

Authors:  Yohan Choi; Fanwei Meng; Charles S Cox; Kevin P Lally; Johnny Huard; Yong Li
Journal:  Int J Cell Biol       Date:  2017-04-10

3.  Twist2 amplification in rhabdomyosarcoma represses myogenesis and promotes oncogenesis by redirecting MyoD DNA binding.

Authors:  Stephen Li; Kenian Chen; Yichi Zhang; Spencer D Barnes; Priscilla Jaichander; Yanbin Zheng; Mohammed Hassan; Venkat S Malladi; Stephen X Skapek; Lin Xu; Rhonda Bassel-Duby; Eric N Olson; Ning Liu
Journal:  Genes Dev       Date:  2019-04-11       Impact factor: 11.361

4.  Emerin anchors Msx1 and its protein partners at the nuclear periphery to inhibit myogenesis.

Authors:  Zhangjing Ma; Huiyuan Shi; Yi Shen; Huixia Li; Yu Yang; Jiange Yang; Hui Zhao; Gang Wang; Jingqiang Wang
Journal:  Cell Biosci       Date:  2019-04-11       Impact factor: 7.133

5.  Alternating Differentiation and Dedifferentiation between Mature Osteoblasts and Osteocytes.

Authors:  Naruhiko Sawa; Hiroki Fujimoto; Yoshihiko Sawa; Junro Yamashita
Journal:  Sci Rep       Date:  2019-09-25       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.